Metformin induced lactic acidosis--particularities and course

Area of Science:

• Pharmacology
• Internal Medicine
• Toxicology

Background:

• Diabetes mellitus is a prevalent condition with significant chronic complications.
• Current oral antidiabetic medications require improvement in mechanism of action and toxicology for better efficacy, compliance, and reduced side effects.
• Metformin, a widely used oral antidiabetic, offers a low risk of hypoglycemia but carries a rare risk of lactic acidosis.

Purpose of the Study:

• To present cases of metformin-associated lactic acidosis.
• To outline the circumstances triggering this adverse event.
• To describe clinical therapeutic measures for affected patients.

Main Methods:

• Case series analysis of 13 patients with metformin-associated lactic acidosis.
• Review of triggering factors and clinical interventions.
• Correlation of patient condition, metformin levels, and prognosis.

Main Results:

• Renal impairment and tissue hypoxia are primary triggers for metformin-associated lactic acidosis.
• Interventions are tailored to patient-specific conditions like hypotension and cardiac arrest.
• Prognosis is linked to associated pathologies and concurrent medications, not solely metformin dosage or plasma levels.

Conclusions:

• Metformin-associated lactic acidosis is a serious adverse event.
• Identifying and managing triggering factors like renal impairment and hypoxia is crucial.
• Patient prognosis depends on comprehensive clinical assessment and management of comorbidities.